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Background: Preventable mortality is a good indicator of possible problems to be investigated in the primary
prevention chain, making it also a useful tool with which to evaluate health policies particularly public health
policies. This study describes inequalities in preventable avoidable mortality in relation to socioeconomic status in
small urban areas of thirty three Spanish cities, and analyses their evolution over the course of the periods
1996–2001 and 2002–2007.
Methods: We analysed census tracts and all deaths occurring in the population residing in these cities from
1996 to 2007 were taken into account. The causes included in the study were lung cancer, cirrhosis, AIDS/HIV,
motor vehicle traffic accidents injuries, suicide and homicide. The census tracts were classified into three groups,
according their socioeconomic level. To analyse inequalities in mortality risks between the highest and lowest
socioeconomic levels and over different periods, for each city and separating by sex, Poisson regression were used.
Results: Preventable avoidable mortality made a significant contribution to general mortality (around 7.5%, higher
among men), having decreased over time in men (12.7 in 1996–2001 and 10.9 in 2002–2007), though not so clearly
among women (3.3% in 1996–2001 and 2.9% in 2002–2007). It has been observed in men that the risks of death are
higher in areas of greater deprivation, and that these excesses have not modified over time. The result in women is
different and differences in mortality risks by socioeconomic level could not be established in many cities.
Conclusions: Preventable mortality decreased between the 1996–2001 and 2002–2007 periods, more markedly in
men than in women. There were socioeconomic inequalities in mortality in most cities analysed, associating a higher
risk of death with higher levels of deprivation. Inequalities have remained over the two periods analysed. This study
makes it possible to identify those areas where excess preventable mortality was associated with more deprived
zones. It is in these deprived zones where actions to reduce and monitor health inequalities should be put into
place. Primary healthcare may play an important role in this process.
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The use of avoidable mortality as a measure of the per-
formance of healthcare services was first introduced by
Rutstein [1], who presented the first theoretical study on
this issue, where he proposed a list of unnecessary diseases
and disabilities or unnecessary untimely deaths, based on
the assertion that if health services had acted correctly,
they would have been prevented or delayed. The definition
and concept of avoidable mortality, as well the list of con-
ditions considered sentinel health events, have changed
over time [2-9] in line with developments in medicine and
technology.
Avoidable mortality can be disaggregated into two
groups [10], according to the type of healthcare interven-
tion: 1) Preventable mortality – having to do with primary
prevention, lifestyle, intervention programmes, etc. and 2)
Amenable mortality – having to do with secondary pre-
vention and directly with healthcare interventions, in the
form of counselling, diagnosis or treatment.
The WHO World Health Report 2000 [11] defines
health systems inclusively, as systems whose primary
aim is to promote, restore and maintain health. From
this point of view, preventable mortality must be consid-
ered a good indicator of possible problems to be investi-
gated in the primary prevention chain, both in health
promotion and protection and in health education [5],
making it also a useful tool with which to evaluate health
policies, particularly public health policies [12].
Studies conducted in several European countries have
linked population socioeconomic indicators with avoid-
able mortality [13-17] and, in particular with preventable
mortality, as a whole or in relation to specific conditions
included under the definition showing higher mortality
rates in the least favoured groups [18-27]. These inequal-
ities are themselves a risk factor for population health
and need to be studied in order to identify the most
vulnerable groups and regions, to put in place specific
interventions [28].
In recent decades, improvements in living conditions
and the increasing inclusiveness of healthcare systems
have reduced premature and, accordingly, avoidable mor-
tality, both amenable and preventable. Several studies have
analysed trends in mortality from avoidable causes over
time in specific regions or groups [5,7,29-32] and found a
decrease, although other studies described increases in
avoidable mortality [33].
Some studies have associated this trend with socioeco-
nomic inequalities, pointing to maintained and even in-
creased socioeconomic inequalities in avoidable mortality
in recent years [13,19,34-38]. Some have analysed avoid-
able mortality in small areas [39-41] or combined their
analysis with a study of the relationship to inequality
[13,15,22,27], associating the most deprived areas with
higher mortality rates.While improvements in indicators such as preventable
and amenable mortality continue to be analysed to
evaluate the quality, access and equity of healthcare sys-
tems [9,42-44], it is also necessary to continue to identify
the zones associated with a higher risk of these causes of
mortality in the urban areas of large cities, where so
much of the population is concentrated, in order to take
specific public health actions aimed at decreasing mor-
tality and reducing inequalities. Studies in small areas of
cities are important as neighbourhood is recognised as a
health determinant independently of individual determi-
nants [45]. In Spain no study has been conducted to date
on overall preventable mortality in small areas of large
cities, so the aim of this study was to describe trends in
preventable mortality and analyse its relationship to so-
cioeconomic inequalities in small areas of 33 large cities
between 1996–2001 and 2002–2007.
Methods
This study was performed within the framework of the
MEDEA project (Socioeconomic and environmental in-
equalities in mortality in small areas of Spanish cities:
http://www.proyectomedea.org) as an ecological study
on preventable mortality trends in small areas of 33
Spanish cities (Figure 1) in the 1996–2001 and 2002–
2007 periods. The population of these cities accounted
for 30.1% of the Spanish population in 2001, according
to figures from the Spanish National Statistics Institute
(NSI). The units analysed were Census Tract (CT) and
all deaths occurring in the population residing in these
cities from 1996 to 2007 were taken into account.
The mortality figures for each CT were obtained from
the death records of the corresponding autonomous com-
munity. Deaths were assigned to census sector according
to their postal address. The percentage of deaths which
could not be assigned to a CT due to problems in locating
the residence varied from 0.02% in Pamplona to 5.0% in
Cartagena-La Unión. Population figures for each CT, sex
and age group (five year intervals) were obtained from the
NSI. For each CT the indicators necessary for socioeco-
nomic classification were obtained from the 2001 Popula-
tion and Housing Census.
The causes of avoidable mortality included in the stu-
dy were considered preventable in the MEDEA project
(Table 1) and are lung cancer, cirrhosis, Acquired Immune
Deficiency Syndrome and Human Immunodeficiency Virus
infection (AIDS and HIV), considered together, motor ve-
hicle traffic accidents injuries, suicide and homicide. These
causes are based on those proposed by Nolte and McKee
[5], adding AIDS and HIV, suicide and homicide, because
of their particular importance as preventable causes, as held
by many recent articles [6,22,26,27,29,36,46,47]. Deaths
occurring between 1996 and 1998 were coded using the
International Classification of Diseases, 9th edition (ICD-9);
Figure 1 Location of the cities analyzed.
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2007. For the first two causes, only deaths occurring before
the age of 75 years were taken into account, following Nolte
and McKee [5]. For the rest of causes, all deaths occurring
were taken into account.
To establish the socioeconomic status of each CT in
each city the following indicators were used: Unemploy-
ment: percentage of people aged over 16 years out of
work (unemployed people and first time job seekers),
out of the total active population.
Education: percentage of people aged over 16 years
who, according to the Spanish National Statistics Regis-
ter figures, cannot read or write, can read and write but
went to school for less than five years or for more than
five years but without terminating primary studies, out
of the total population aged 16 years and over.
Education in young people: percentage of persons aged
between 16 and 29 years with low educational levels, out
of the total population aged between 16 and 29 years.
Manual workers: percentage of persons aged 16 years
employed in manual labour (services, agriculture, farming,
fishing, crafts, specialised manufacture industry workers,
construction, mining, installers and non-specialised workers)out of the total number of persons in employment aged
16 years or over.
Temporary workers: percentage of people aged 16 years
or over employed in temporary jobs (part-time self-
employed workers, temporary workers) out of the total
of persons in employment aged 16 years or over.
These indicators had previously been used on the
MEDEA project [48] and were used to build socioeco-
nomic status (SES) variables in each city. Three levels
were established: SES1 (the most privileged socioeco-
nomic group), which includes all CTs in the city with
values below the 25th percentile for all five indicators;
SES3 (the least privileged socioeconomic group), which
represents all CTs with values above the 75th percentile
for all indicators; all other CTs were included in SES2
(intermediate socioeconomic level). This variable had
previously been used to classify CTs by socioeconomic
level and proved to be a good tool [22].
Frequencies and percentages (of total preventable
deaths and death from all causes) were calculated for all
causes studied and all preventable causes in each city.
To study the trend in risk of death over time, the dates
were classified into two time periods: 1996–2001 (P1)
Table 1 Frequencies and percentages with regard to the overall mortality by sex, age, period and cause of death(*) in
all the 33 cities studied
Period Sex Age Lung cancer Cirrhosis AIDS, HIV Motor vehicle injuries Suicide Homicide All preventable All causes
n % n % n % n % n % n % n % n %
1996-2001 Men 0-44 744 2.9 866 3.4 4370 17.1 3209 12.5 1524 6.0 308 1.2 11021 43.1 25595 100
45-64 8690 15.0 3232 5.6 798 1.4 1138 2.0 817 1.4 107 0.2 14782 25.5 58052 100
>64 10427 4.4 2497 1.1 144 0.1 979 0.4 955 0.4 41 0.0 15043 6.3 237720 100
Total 19861 6.2 6595 2.1 5312 1.7 5326 1.7 3296 1.0 456 0.1 40846 12.7 321367 100
Women 0-44 274 2.5 209 1.9 1140 10.2 908 8.1 479 4.3 98 0.9 3108 27.9 11157 100
45-64 1095 4.3 949 3.7 127 0.5 436 1.7 387 1.5 42 0.2 3036 11.9 25524 100
>64 997 0.4 1458 0.6 30 0.0 693 0.3 493 0.2 44 0.0 3715 1.4 263798 100
Total 2366 0.8 2616 0.9 1297 0.4 2037 0.7 1359 0.5 184 0.1 9859 3.3 300479 100
2002-2007 Men 0-44 656 3.1 702 3.3 1908 9.0 2486 11.7 1563 7.4 393 1.9 7708 36.4 21172 100
45-64 9323 16.2 2988 5.2 876 1.5 900 1.6 984 1.7 148 0.3 15219 26.4 57622 100
>64 9739 3.8 1962 0.8 136 0.1 810 0.3 1046 0.4 50 0.0 13743 5.4 256376 100
Total 19718 5.9 5652 1.7 2920 0.9 4196 1.3 3593 1.1 591 0.2 36670 10.9 335170 100
Women 0-44 316 3.2 195 2.0 561 5.7 582 5.9 535 5.4 133 1.3 2322 23.5 9896 100
45-64 1958 7.5 803 3.1 122 0.5 276 1.1 525 2.0 62 0.2 3746 14.4 26095 100
≥64 1230 0.4 966 0.3 24 0.0 547 0.2 492 0.2 55 0.0 3314 1.1 291098 100
Total 3504 1.1 1964 0.6 707 0.2 1405 0.4 1552 0.5 250 0.1 9382 2.9 327089 100
1996-2007 Men 0-44 1400 3.0 1568 3.4 6278 13.4 5695 12.2 3087 6.6 701 1.5 18729 40.0 46767 100
45-64 18013 15.6 6220 5.4 1674 1.4 2038 1.8 1801 1.6 255 0.2 30001 25.9 115674 100
>64 20166 4.1 4459 0.9 280 0.1 1789 0.4 2001 0.4 91 0.0 28786 5.8 494096 100
Total 39579 6.0 12247 1.9 8232 1.3 9522 1.5 6889 1.0 1047 0.2 77516 11.8 656537 100
Women 0-44 590 2.8 404 1.9 1701 8.1 1490 7.1 1014 4.8 231 1.1 5430 25.8 21053 100
45-64 3053 5.9 1752 3.4 249 0.5 712 1.4 912 1.8 104 0.2 6782 13.1 51619 100
>64 2227 0.4 2424 0.4 54 0.0 1240 0.2 985 0.2 99 0.0 7029 1.3 554896 100
Total 5870 0.9 4580 0.7 2004 0.3 3442 0.5 2911 0.5 434 0.1 19241 3.1 627568 100
Spain, 1996-2007.
(*)ICD codes and age: Lung cancer (ICD-9: 162; ICD-10: C33,C34; Age: 0–74), Cirrhosis (ICD-9: 571, 573.0; ICD-10: K70, K72.1, K73, K74, K76.1.9, Age: 0–74), AIDS
and HIV (ICD-9: 279.1.5.6.8, 042, 795.8; ICD-10: B20-B24, R75; Age: all), Motor vehicle injuries (ICD-9: E810-E825; ICD-10: V02-V04, V09.0.2, V12-V14, V19.0.1.2.4.5.6,
V20-V79, V80.3.4.5, V81.0.1, V82.0.1, V83-V86, V87-V88.0.1.2.3.4.5.6.7.8, V89.0.2; Age: all), Suicide (ICD-9: E950-E959; ICD-10: X60-X84; Age: all), Homicide (ICD-9:
E960-E969; ICD-10: X85-Y09; Age: all).
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Lugo, Ourense, Pontevedra, Santiago and Vigo mortality
figures were available from 1998 onwards, so for these
cities the first period goes from 1998 to 2001). The age
standardised mortality rates (ASR) and their 95% confi-
dence intervals were calculated for all preventable cases,
adjusted using the direct method and taking as standard
the Spanish population in 2001 (centre of the period) by
sex and age group, obtained from the NSI, for each city,
in each period and by sex.
To analyse inequalities in mortality risks between the
highest and lowest socioeconomic levels and over different
periods, for each city and separating by sex, Poisson re-
gression models with variable responses to the rate of
death logarithm were adapted, using variables explaining
SES (reference level:SES1), period (reference level: P1) and
age, into three groups: younger than 45 years (referencelevel), 45 to 64 and older than 64 years. The age limit of
65 years was chosen as it is the cut-off age normally used
in studies to define ‘old age’ [49]. Subjects aged under 65
were classified into two groups, depending on the lesser
or greater prematurity of death. This model made it pos-
sible to estimate the Relative Risk (RR) of death and the
corresponding 95% confidence intervals for each level of
explicative SES variables, period and age group compared
to the chosen reference level. We analysed possible inter-
actions between SES and period, SES and age group and
between age group and period. The existence of significant
interaction between SES and period demonstrates the
change between RR periods across socioeconomic levels.
In order to control for overdispersion, which takes place
when a certain distribution for the data is assumed and
the variability of these data is higher than the one ex-
pected from the model assumed, quasi-likelihood models
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cise likelihood for the answers and enable modelling on
the basis of the linear predictor and the form assumed to
represent the variance based on the average [50]. In the
case of Poisson models, the variance function is supposed
to differ only by a scale factor ϕ from the variance function
in the corresponding likelihood model, i.e. Variance =ϕ
Mean. In this way, the estimations of the parameters are
equal. Nevertheless, the standard errors obtained by quasi-
likelihood are the maximum likelihood estimators multi-
plied by ϕ ½. In order to control overdispersion in Poisson
models, the parameter ϕ has been estimated. It has been
tested whether it is statistically different from the unit. The
estimator of ϕ takes the form D/df, where D is the devi-
ance of the Poisson model adjusted, and df the degrees of
freedom. If it is different from the unit, a quasi-Poisson
model is adjusted, which is the appropriate model when
there is overdispersion. This comparison and the estima-
tion of all the models have been conducted by means of
the R statistics package 2.12.2.
Results
The populations and number of census tracts (CTs) in the
cities analysed (Table 2) varied, according to 2001 figures,
from a minimum of 75864 inhabitants and 57 sectors in
Pontevedra to a maximum of 2874732 inhabitants and
2358 sectors in Madrid, with an mean population of
373283 inhabitants per city, with a mean of 297 sectors
per city and a mean sector size of 1257 inhabitants.
The total number of preventable deaths for all cities in
the period analysed was 96757. Of these, 77516 were
men and 19241 were women, accounting for 11.8% and
3.1% of all deaths, respectively (Table 1). By periods and
for all cities, there was a reduction in the number of pre-
ventable deaths in men, from 40846 in the 1996–2001
period to 36670 in the 2002–2007 period. This drop was
attributable mainly to AIDS and HIV, road traffic acci-
dents, cirrhosis and, to a lesser degree, lung cancer, while
the number of suicides and homicides rose. There was
also a reduction, albeit a smaller one, in the number of
preventable deaths among women, from 9859 in the first
period to 9382 in the second, with fewer deaths from
AIDS, HIV, cirrhosis and road traffic accidents, with
higher numbers of deaths from lung cancer, suicide and
homicide.
Table 2 shows the frequencies and percentages of deaths
(compared to total preventable deaths) per city, sex and
specific cause. The most frequent cause for men, in all cit-
ies, was lung cancer, with a percentage out of total deaths
from all causes varying from 37.8% in Jaén to 58.5% in
Coruña. In the case of women, in 20 of the 33 cities ana-
lysed (60.6%) the most frequent cause of death was lung
cancer, in 7 cities (21.2%) it was cirrhosis, and in 6 (18.2%)
it was road traffic accidents.Table 3 shows the age standardized rates (ASRs) for all
preventable deaths studied for each city, sex and period.
In the case of men, there is an average decrease of 15.7%,
with a decrease of all the rates adjusted in every city.
Women showed a mean reduction of 11.3%, although
some cities such as Avilés, Lugo, Pamplona and Ponteve-
dra showed slight increases in the second period.
Figures 2 and 3 show the RRs of death between the
least privileged and most privileged levels (SES3 and
SES1, respectively) of the SES variables estimated using
Poisson regression. These relative risks show the excess
risk of death at the lowest level (SES3) compared to the
highest level (SES1). The estimated RRs are presented by
age groups, as significant interaction between age group
and SES was detected in several cases. Nevertheless, no
significant interaction was detected between the period
under analysis and SES, there being accordingly no evi-
dence that RRs among SES levels vary between periods
in any city, in men or in women.
In men (Figure 2) the RR of death in SES3 compared
to SES1 was higher than 1 in all cities and at all ages,
significantly so (p < 0.05) in 26 cities in the 0–44 age
group, in 27 cities in the 45–64 age group, and in 21 cit-
ies in the group aged over 64 years. Significant inter-
action was detected between age group and SES in 11 of
the 33 cities analysed, while in the rest the SES effect
was constant over the three age groups. In general, the
interaction detected translates into higher RRs among
SES levels for the youngest groups. This is the case, for
example, of Madrid, with RRs of 3.9 in the 0–44 age
group, 2.2 in the 45–64 age group, 2.2 in the 45–64 age
group and 1.8 in the group aged 65 or over.
In the case of women (Figure 3), the estimated RR
were higher than 1 in 27 cities in the 0–44 age group
(significantly so in 9 cities), in 26 cities in the 45–64 age
group (significant in 3 cities) and in 20 cities in the
group aged 64 years and older (significant in 5 cities).
There was significant interaction between SES and age
group in 5 of the 33 cities studied; in the rest the SES ef-
fect was constant over the three age groups. The inter-
action effect detected in these cities was due, as in men,
to significant excesses in risk among younger women.
Table 4 shows the median and mean calculated using
the relative risks of the 33 cities when SES3 and SES1
are compared. It shows that, on average, the RRs for the
SES variable decreased with age, being highest in the 0–
44 years age group.
Discussion
This is the first time that preventable avoidable mortality
has been analyzed in such a high number of Spanish cit-
ies. Using data from thirty-three major Spanish cities,
basic socioeconomic indicators of the educational and
working environment have been used in this study to
Table 2 Characteristics of the studied cities: population, number of census tracts (CTs) and percentage of sections in
worse socioeconomic status (SES3)
City (Population 2001) CTs % CTs.
in SES3
Sex(*) Lung cancer Cirrhosis AIDS-VIH Motor vehicle
accidents
Suicide Homicide TOTAL preventable
n % n % n % n % n % n % n %
ALICANTE 215 9.3 M 921 48.4 301 15.8 199 10.5 259 13.6 191 10.0 32 1.7 1903 100
(283243) W 144 28.9 131 26.3 53 10.6 81 16.3 77 15.5 12 2.4 498 100
ALMERIA 118 10.2 M 443 42.2 152 14.5 107 10.2 209 19.9 103 9.8 36 3.4 1050 100
(176709) W 38 18.4 51 24.8 19 9.2 54 26.2 36 17.5 8 3.9 206 100
AVILES 72 8.3 M 352 54.0 109 16.7 40 6.1 77 11.8 66 10.1 8 1.2 652 100
(83553) W 42 30.9 27 19.9 8 5.9 33 24.3 23 16.9 3 2.2 136 100
BARCELONA 1491 8.7 M 5761 56.5 1563 15.3 985 9.7 869 8.5 920 9.0 90 0.9 10188 100
(1505336) W 900 31.4 813 28.3 262 9.1 383 13.3 450 15.7 62 2.2 2870 100
BILBAO 288 8.0 M 1356 50.8 458 17.2 310 11.6 268 10.0 255 9.6 23 0.9 2670 100
(349972) W 244 31.5 181 23.4 110 14.2 107 13.8 117 15.1 16 2.1 775 100
CADIZ 111 11.7 M 522 49.5 237 22.5 133 12.6 94 8.9 66 6.3 3 0.3 1055 100
(133242) W 46 17.7 122 46.9 29 11.2 25 9.6 34 13.1 4 1.5 260 100
CARTAGENA-LU 146 8.2 M 667 44.7 221 14.8 123 8.2 291 19.5 161 10.8 30 2.0 1493 100
(212952) W 70 22.9 73 23.9 36 11.8 70 22.9 48 15.7 9 2.9 306 100
CASTELLON 95 5.3 M 481 48.0 118 11.8 94 9.4 194 19.4 107 10.7 8 0.8 1002 100
(146563) W 59 27.1 39 17.9 14 6.4 54 24.8 46 21.1 6 2.8 218 100
CORDOBA 224 10.7 M 885 46.0 336 17.5 291 15.1 222 11.5 174 9.0 17 0.9 1925 100
(319692) W 79 21.6 81 22.2 60 16.4 81 22.2 52 14.2 12 3.3 365 100
CORUNA 181 4.4 M 733 58.5 121 9.7 99 7.9 141 11.3 149 11.9 10 0.8 1253 100
(239434) W 96 28.5 62 18.4 25 7.4 77 22.8 72 21.4 5 1.5 337 100
FERROL 69 7.2 M 274 55.6 82 16.6 36 7.3 48 9.7 49 9.9 4 0.8 493 100
(80347) W 43 31.9 30 22.2 16 11.9 23 17.0 21 15.6 2 1.5 135 100
GIJON 191 5.2 M 1063 50.5 379 18.0 161 7.6 227 10.8 250 11.9 26 1.2 2106 100
(269270) W 150 28.5 113 21.5 50 9.5 104 19.8 101 19.2 8 1.5 526 100
GRANADA 181 12.7 M 589 39.6 324 21.8 192 12.9 206 13.9 152 10.2 23 1.5 1486 100
(237720) W 88 22.6 114 29.2 28 7.2 67 17.2 78 20.0 15 3.8 390 100
HUELVA 101 10.9 M 475 47.5 150 15.0 178 17.8 128 12.8 61 6.1 8 0.8 1000 100
(144369) W 44 21.9 49 24.4 36 17.9 34 16.9 32 15.9 6 3.0 201 100
JAEN 76 11.8 M 250 37.8 200 30.3 40 6.1 73 11.0 88 13.3 10 1.5 661 100
(115917) W 23 16.1 60 42.0 8 5.6 21 14.7 29 20.3 2 1.4 143 100
LAS PALMAS 263 9.1 M 981 47.5 415 20.1 178 8.6 237 11.5 224 10.8 31 1.5 2066 100
(364775) W 178 36.8 93 19.2 42 8.7 74 15.3 86 17.8 11 2.3 484 100
LOGRONO 91 4.4 M 333 42.7 85 10.9 76 9.7 166 21.3 116 14.9 4 0.5 780 100
(131143) W 39 20.2 27 14.0 14 7.3 68 35.2 40 20.7 5 2.6 193 100
LUGO 69 2.9 M 216 51.2 44 10.4 24 5.7 81 19.2 51 12.1 6 1.4 422 100
(88901) W 29 20.7 24 17.1 5 3.6 49 35.0 28 20.0 5 3.6 140 100
MADRID 2358 7.5 M 9213 54.5 2504 14.8 2276 13.5 1643 9.7 969 5.7 312 1.8 16917 100
(2874732) W 1593 37.5 960 22.6 498 11.7 733 17.2 362 8.5 104 2.4 4250 100
MALAGA 422 9.2 M 1708 46.0 653 17.6 448 12.1 479 12.9 359 9.7 67 1.8 3714 100
(546601) W 202 24.9 238 29.3 85 10.5 107 13.2 168 20.7 11 1.4 811 100
MURCIA 295 3.7 M 960 44.4 384 17.7 118 5.5 461 21.3 207 9.6 34 1.6 2164 100
(398815) W 103 26.1 85 21.5 24 6.1 97 24.6 71 18.0 15 3.8 395 100
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Table 2 Characteristics of the studied cities: population, number of census tracts (CTs) and percentage of sections in
worse socioeconomic status (SES3) (Continued)
OURENSE 79 3.8 M 275 51.8 53 10.0 40 7.5 97 18.3 61 11.5 5 0.9 531 100
(109051) W 51 35.4 19 13.2 7 4.9 27 18.8 33 22.9 7 4.9 144 100
OVIEDO 173 8.7 M 720 51.4 235 16.8 106 7.6 160 11.4 163 11.6 16 1.1 1400 100
(201005) W 118 33.7 54 15.4 23 6.6 77 22.0 71 20.3 7 2.0 350 100
PAMPLONA 122 4.1 M 562 52.7 97 9.1 79 7.4 173 16.2 146 13.7 9 0.8 1066 100
(173272) W 105 35.4 33 11.1 30 10.1 72 24.2 53 17.8 4 1.3 297 100
PONTEVEDRA 57 5.3 M 191 50.7 36 9.5 38 10.1 73 19.4 38 10.1 1 0.3 377 100
(75864) W 25 24.8 22 21.8 14 13.9 23 22.8 17 16.8 0 0.0 101 100
SAN SEBASTIAN 140 5.7 M 573 50.8 186 16.5 88 7.8 159 14.1 111 9.8 11 1.0 1128 100
(178377) W 130 37.8 58 16.9 25 7.3 60 17.4 66 19.2 5 1.5 344 100
S. C. TENERIFE 157 6.4 M 606 49.4 227 18.5 130 10.6 129 10.5 124 10.1 11 0.9 1227 100
(214153) W 115 42.8 58 21.6 26 9.7 35 13.0 30 11.2 5 1.9 269 100
SANTIAGO 73 4.1 M 242 54.6 48 10.8 23 5.2 86 19.4 42 9.5 2 0.5 443 100
(93381) W 42 36.2 15 12.9 6 5.2 42 36.2 10 8.6 1 0.9 116 100
SEVILLA 510 12.7 M 2205 49.2 800 17.9 481 10.7 530 11.8 408 9.1 55 1.2 4479 100
(704305) W 256 28.6 230 25.7 89 9.9 151 16.9 154 17.2 15 1.7 895 100
VALENCIA 533 8.5 M 2623 49.5 847 16.0 629 11.9 663 12.5 456 8.6 80 1.5 5298 100
(746612) W 345 23.8 429 29.6 206 14.2 191 13.2 246 17.0 34 2.3 1451 100
VIGO 236 4.7 M 751 52.0 182 12.6 126 8.7 217 15.0 143 9.9 26 1.8 1445 100
(287282) W 133 34.3 72 18.6 37 9.5 81 20.9 56 14.4 9 2.3 388 100
VITORIA 168 4.2 M 559 44.2 184 14.6 98 7.8 245 19.4 166 13.1 12 0.9 1264 100
216852) W 81 24.9 60 18.5 36 11.1 91 28.0 51 15.7 6 1.8 325 100
ZARAGOZA 462 5.4 M 2089 54.1 516 13.4 286 7.4 617 16.0 313 8.1 37 1.0 3858 100
(614905) W 259 28.1 157 17.0 83 9.0 250 27.1 153 16.6 20 2.2 922 100
(*) M: Men, W:Women.
Frequency and percentage of deaths (relative to the total preventable deaths) for each preventable cause, sex and city. Spain, 1996–2007.
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avoidable mortality and thus to detect urban areas to
investigate possible problems in the chain of primary
prevention, both in the promotion and protection of
health and in health education, or over which should
address specific health policies. The existence of pre-
ventable mortality inequalities should be an indicator of
differences in health policy outcomes between different
socioeconomic groups. The results of this study show
that preventable avoidable mortality made a significant
contribution to general mortality (around 7.5%, higher
among men), having clearly decreased over time in men
(12.7 in 1996–2001 and 10.9 in 2002–2007), though not
so clearly among women (3.3% in 1996–2001 and 2.9%
in 2002–2007). In the thirty-three cities studied, it has
been observed in men, with great consistency, that the
risks of death are higher in areas of greater deprivation,
and that these excesses have not modified over time.
The result in women was different and differences in
mortality risks by socioeconomic level could not be
established in many cities.Preventable deaths as a percentage of general mortality
dropped between the first and second periods. Men con-
tributed more heavily to the reduction, which was a con-
sequence of the drop in mortality from AIDS and HIV,
road traffic injuries, cirrhosis and other liver diseases
and, to a lesser degree, lung cancer. For men there was a
drop in ASRs in all cities. The effect was different in
women, who experienced an increase in the percentage
of avoidable deaths between the first and second period,
due to lung cancer, suicide and homicide. Consequently,
there was greater variability in mortality risk trends, and
ASRs increased between the first and second periods in
several cities.
The general downward tendency coincides with other
studies on avoidable mortality [29,30]. Grabauskas et al.
described a growing tendency in avoidable mortality in
Lithuania [33]. By causes, in Spain, Dalmau-Bueno et al.
found a decrease in deaths due cirrhosis between 1992
and 2004 in Barcelona, in both men and women [23].
Other studies have described a reduction in AIDS and
HIV mortality, particularly as a consequence of Highly
Table 3 Age standardized mortality rates (95%CI) for the 33 cities studied, by sex and period
CITY SEX 1996-2001 2002-2007 1996-2007
ALICANTE Men 134.1 (125.9-142.3) 99.3 (92.7-105.9) 115.5 (110.3-120.7)
Women 29.1 (25.4-32.7) 26.1 (22.8-29.3) 27.5 (25.1-29.9)
ALMERIA Men 130.2 (119.1-141.3) 111.1 (101.3-120.8) 120.1 (112.8-127.5)
Women 21.9 (17.6-26.2) 19.9 (16.0-23.8) 20.9 (18.0-23.8)
AVILES Men 131.3 (117.3-145.3) 114.4 (101.5-127.3) 122.5 (113.0-131.9)
Women 22.8 (17.0-28.5) 25.3 (19.5-31.0) 24.2 (20.1-28.3)
BARCELONA Men 119.2 (116.1-122.4) 93.9 (91.2-96.6) 105.9 (103.9-108.0)
Women 28.7 (27.2-30.1) 24.3 (23.0-25.6) 26.4 (25.4-27.4)
BILBAO Men 132.9 (126.0-139.7) 108.1 (101.9-114.2) 120.7 (116.1-125.3)
Women 33.7 (30.4-37.0) 30.4 (27.3-33.6) 32.1 (29.8-34.4)
CÁDIZ Men 152.6 (140.0-165.3) 121.9 (111.0-132.9) 137.1 (128.7-145.4)
Women 35.5 (29.8-41.3) 25.5 (20.7-30.3) 30.5 (26.7-34.2)
CARTAGENA Men 145.9 (135.3-156.4) 127.4 (118.2-136.6) 135.6 (128.7-142.5)
Women 29.6 (25.1-34.2) 23.6 (19.7-27.5) 26.6 (23.6-29.6)
CASTELLÓN Men 135.2 (123.6-146.8) 106.3 (96.7-115.9) 118.7 (111.3-126.1)
Women 28.4 (23.2-33.5) 21.5 (17.3-25.7) 24.7 (21.4-28.0)
CORDOBA Men 132.6 (124.5-140.8) 103.0 (96.3-109.8) 117.0 (111.7-122.2)
Women 21.7 (18.6-24.8) 18.1 (15.4-20.8) 19.7 (17.7-21.7)
CORUÑA Men 111.7 (102.1-121.4) 96.5 (89.4-103.5) 102.3 (96.6-107.9)
Women 26.1 (21.8-30.4) 22.4 (19.2-25.5) 23.9 (21.4-26.5)
FERROL Men 123.7 (106.6-140.9) 116.1 (102.7-129.6) 119.8 (109.2-130.4)
Women 29.7 (21.6-37.7) 28.0 (21.8-34.2) 28.8 (23.9-33.7)
GIJÓN Men 132.9 (125.1-140.8) 109.9 (103.0-116.8) 121.2 (116.0-126.4)
Women 29.8 (26.1-33.4) 27.0 (23.6-30.3) 28.3 (25.8-30.7)
GRANADA Men 128.5 (119.6-137.4) 103.4 (95.6-111.2) 115.3 (109.4-121.2)
Women 25.1 (21.5-28.7) 25.4 (21.9-29.0) 25.2 (22.7-27.7)
HUELVA Men 150.9 (137.7-164.1) 125.5 (114.2-136.8) 136.7 (128.2-145.3)
Women 25.2 (20.2-30.3) 23.3 (18.7-27.8) 24.3 (20.9-27.7)
JAÉN Men 126.3 (112.5-140.2) 112.6 (100.5-124.8) 118.6 (109.5-127.6)
Women 23.6 (17.9-29.3) 22.5 (17.4-27.6) 23.1 (19.3-26.9)
LAS PALMAS Men 121.4 (114.2-128.6) 89.9 (84.1-95.8) 104.9 (100.3-109.5)
Women 25.3 (22.1-28.5) 21.3 (18.5-24.0) 23.1 (21.0-25.2)
LOGROÑO Men 114.5 (103.4-125.5) 93.4 (83.8-103.0) 103.3 (96.0-110.5)
Women 26.9 (21.7-32.1) 20.3 (16.1-24.6) 23.6 (20.2-26.9)
LUGO Men 103.9 (88.4-119.5) 92.5 (81.0-104.0) 96.6 (87.4-105.9)
Women 27.2 (19.8-34.6) 28.8 (22.7-34.8) 28.1 (23.4-32.8)
MADRID Men 107.8 (105.6-110.0) 85.2 (83.2-87.1) 95.8 (94.3-97.2)
Women 22.4 (21.5-23.4) 19.6 (18.7-20.4) 20.9 (20.2-21.5)
MÁLAGA Men 144.4 (137.9-151.0) 122.4 (116.7-128.1) 132.5 (128.2-136.8)
Women 27.2 (24.6-29.9) 24.2 (21.8-26.6) 25.7 (23.9-27.4)
MURCIA Men 119.6 (112.4-126.8) 104.6 (98.3-110.9) 111.2 (106.5-115.9)
Women 20.6 (17.7-23.4) 17.3 (14.9-19.8) 18.8 (16.9-20.6)
OURENSE Men 110.5 (95.9-125.1) 93.9 (83.3-104.4) 100.1 (91.5-108.7)
Women 23.8 (17.4-30.1) 23.6 (18.7-28.6) 23.7 (19.8-27.6)
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Table 3 Age standardized mortality rates (95%CI) for the 33 cities studied, by sex and period (Continued)
OVIEDO Men 124.8 (115.7-133.9) 107.6 (99.4-115.8) 115.9 (109.8-122.0)
Women 27.6 (23.6-31.6) 22.3 (18.8-25.7) 24.8 (22.2-27.4)
PAMPLONA Men 111.9 (102.4-121.3) 95.1 (86.8-103.3) 103.0 (96.8-109.2)
Women 25.0 (20.8-29.3) 27.4 (23.1-31.7) 26.1 (23.1-29.1)
PONTEVEDRA Men 120.3 (101.5-139.0) 100.7 (87.3-114.2) 108.0 (97.0-118.9)
Women 23.9 (16.0-31.7) 26.3 (19.9-32.8) 25.2 (20.3-30.2)
SAN SEBASTIÁN Men 114.2 (104.9-123.4) 96.4 (88.2-104.6) 105.5 (99.3-111.7)
Women 31.2 (26.7-35.7) 24.1 (20.3-27.9) 27.7 (24.8-30.7)
SANTA CRUZ de TENERIFE Men 113.3 (104.2-122.3) 101.0 (92.9-109.0) 106.9 (100.9-112.9)
Women 21.0 (17.3-24.6) 20.5 (17.1-24.0) 20.8 (18.3-23.3)
SANTIAGO Men 101.4 (86.3-116.5) 99.9 (87.9-111.9) 100.7 (91.3-110.1)
Women 29.1 (21.5-36.8) 19.4 (14.5-24.3) 23.2 (19.0-27.5)
SEVILLA Men 133.1 (127.7-138.6) 109.7 (105.0-114.4) 120.9 (117.4-124.5)
Women 21.8 (19.8-23.8) 20.2 (18.3-22.1) 21.0 (19.6-22.4)
VALENCIA Men 135.0 (130.1-140.0) 107.3 (103.0-111.5) 120.4 (117.1-123.6)
Women 33.5 (31.1-35.8) 25.6 (23.6-27.6) 29.4 (27.9-31.0)
VIGO Men 107.1 (98.2-115.9) 102.3 (95.5-109.1) 104.4 (99.0-109.8)
Women 25.8 (21.7-30.0) 24.9 (21.7-28.1) 25.2 (22.7-27.7)
VITORIA Men 105.2 (97.1-113.3) 87.3 (80.3-94.3) 95.8 (90.5-101.1)
Women 30.8 (26.4-35.2) 18.6 (15.3-21.8) 24.4 (21.7-27.1)
ZARAGOZA Men 110.8 (105.9-115.6) 95.8 (91.3-100.2) 103.1 (99.9-106.4)
Women 23.2 (21.1-25.3) 22.6 (20.5-24.6) 22.9 (21.4-24.4)
Spain, 1996-2007.
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Borrell et al. in Barcelona [19] and Regidor et al. in the
Madrid region [24]. With regard to lung cancer, the gen-
eral tendency in European countries points towards a re-
duction among men (particularly young men) and an
increase among women [51]. In Spain, the results are
similar, rising among women and falling among men [32].
The socioeconomic inequalities found in this study for
all deaths from preventable causes confirm the others.
Thus, Gotsens et al. found socioeconomic inequalities in
15 European cities for death from injuries (road traffic
injuries, suicide, homicide, other external causes) be-
tween 2000 and 2008 [26]. Socioeconomic inequalities
were also found in AIDS and HIV mortality in cities
such as Barcelona [20], in mortality from cirrhosis in
Zaragoza [25] or inequalities in educational level in mor-
tality from AIDS, cirrhosis and accident and suicide in-
juries in the Madrid region [18], and for the lung cancer,
cirrhosis, motor traffic accident injuries and AIDS in
Castellón, Valencia and Alicante [22].
In this study we found no changes in time in the effects
of socioeconomic inequalities on mortality, as the effects
of the interaction between SES and period were not sig-
nificant in any city. Thus we may interpret that the in-
equalities remained constant in both periods. Consideringthe 33 cities studied, in the case of men the median RR be-
tween SES3 and SES1 did not differ between the two pe-
riods for any age group, varying from 1.7 and 1.8, in the
group aged over 65 years, in the first and second periods,
respectively, and 3.3 (period 1) and 3.0 (period 2) in the
group aged under 45 years. These findings consistently
show the existence of generalised socioeconomic inequal-
ities for all preventable causes analysed for men. In the
case of women, the median for the three RRs is roughly 1
for the group aged over 65 years and, in the group aged
under 45, 2.1 for the first period and 1.9 for the second
one. Although the results are not significant in many cities
and age groups, the estimated RRs are mainly higher than
1, indicating inequality between SES levels, though not
quite so pronounced as in men. The lack of statistical sig-
nificance may be due to the lower number of deaths
among women in comparison with men. The results ob-
tained in the group aged over 65 years are in the same
range as those presented by Huisman et al. [49], who
reviewed socioeconomic inequalities in mortality in old age
in the World Health Organization Europe Region and
found that RR are rarely higher than 2.0.
Some studies in other countries point either to an in-
crease in socioeconomic inequalities in preventable causes
[36,52] or to their decrease [13]. In the case of the causes
($) SES = Socioeconomic status 
(*) Significant interaction (p<0.05) between age and SES 
Figure 2 Relative Risk (RR) of death and 95% confidence interval (95% CI) in SES3 vs. SES1$ for men in each city, by age group.
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study conducted in Barcelona using figures from the
1992–2003 period, Borrell et al. [21] found that inequal-
ities in mortality by educational level did not change sub-
stantially over time. There are studies which point to an
increase in socioeconomic inequalities due to cirrhosis
[34,53] or towards their remaining the same or increasing
in certain age groups [23]. In the case of AIDS and HIV
several studies show that socioeconomic inequalities have
been maintained over time [19,20]. In the case of sui-
cide, studies conducted in other countries have foundthat socioeconomic inequalities either remained steady
[52,54] or increased over time [55]. In a study con-
ducted on men in 26 Spanish cities, Gotsens et al. [27]
found that socioeconomic inequalities in mortality from
injuries (including drug overdose, road traffic injuries
and suicide) did not change between the 1996–2001
and 2002–2007 periods. The results of this study are
similar to those observed in a study conducted in
Valencia, Castellón and Alicante analysing trends in
socioeconomic inequalities in mortality from preventable
causes (lung cancer, cirrhosis, traffic accidents injuries and
($) SES = Socioeconomic status 
(*) Significant interaction (p<0.05) between age and SES 
Figure 3 Relative Risk (RR) of death and 95% confidence interval (95% CI) in SES3 vs. SES1$ for women in each city, by age group.
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presenting a similar differential effect between men and
women (higher RRs in men).
We believe special attention should be paid to age group
inequalities, as this study shows that it is the under
45 years group where the greatest inequality occurs. In all
cities where significant interaction was detected between
SES and age (14 cities for men and 5 for women), it was in
the under 45 years age group where the highest RR was
estimated. This result offers clear guidelines for interven-
tions aimed at reducing inequalities.In a study conducted on 11 Spanish cities [56], varying
patterns in relation between size of city and magnitude of
socioeconomic inequalities in mortality were found, par-
ticularly a certain link to lung cancer and cirrhosis in men.
Looking at the population characteristics of the cities
analysed we can see that the geographical distribution
of cities according to the percentage of CTs at the most
deprived level (SES3) shows a certain grouping. Thus,
the percentage for Lugo, Murcia, Ourense, Pamplona,
Santiago, Vitoria, Logroño, Coruña, Vigo, Gijón, Castellón,
Pontevedra, Zaragoza, San Sebastián, Santa Cruz de
Table 4 Median, 10% truncated mean and standard deviation for the Relative Risk when comparing SES3 vs. SES 1$ in
the studied cities, by age group, period and sex
Age group Period Men Women
Median n(*) Mean SD Median n(*) Mean SD
0-44 years 1996-2001 3.3 27 3.3 1.1 2.1 28 2.2 1.6
2002-2007 3.0 27 3.0 0.7 1.9 28 2.4 1.5
45-64 years 1996-2001 2.1 27 2.2 0.6 1.3 28 1.6 1.2
2002-2007 2.3 28 2.4 0.8 1.2 28 1.3 0.5
>64 years 1996-2001 1.8 27 1.9 0.6 1.0 27 1.4 0.8
2002-2007 1.7 29 1.7 0.5 1.2 27 1.5 0.9
($) SES = Socioeconomic status.
(*) Number of cities.
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other cities – Madrid, Bilbao, Cartagena-La Unión,
Avilés, Valencia, Oviedo, Barcelona, Las Palmas, Málaga,
Alicante, Almería, Córdoba, Huelva, Cádiz, Jaén, Granada
and Sevilla, are above it. We could say that the first group
are clearly in the northern part of Spain (except Murcia
and Castellón), while the rest are in the southern and
Mediterranean parts (except Avilés, Oviedo and Bilbao).
This result leads to the conclusion that higher proportions
of deprived populations, according to the calculated
indicator, lived in cities in the southern and Mediterra-
nean regions of Spain. However, when we inspected the
relationship between population size and percentage of
CTs in level SES3 with socioeconomic inequalities (RRs of
SES3 vs. SES1), low or moderate Spearman correlations
were obtained (below 0.30 and non-significant), showing a
weak relationship between inequalities and city size and
percentage of deprived CTs.
This study has its limitations. First of all, we have to
take into account that it is an ecological study, with the
constraints inherent to this type of study. Thus, it does
not allow the proof of a causal association. The associ-
ation found between SES and mortality using CTs may
not be applicable at an individual level (i.e. ecological fal-
lacy) and the ecological associations found may reflect
both the effect of individual socioeconomic level and the
contextual effect of the area. Regarding the causes ana-
lysed, other lists could have been used. The causes were
chosen on the basis of comparability with other studies
and it should be taken into account that exposure to risk
factors for some of the causes analysed may have oc-
curred in places other than the place of residence, such
as in the work place, as the persons most exposed may
live in very deprived neighbourhoods. Nevertheless, an
analysis using small areas makes it possible to chase
down and identify populations at risk, although some of
the exposure may occur outside of them. Another con-
straint may arise from the use of different mortality clas-
sifications throughout the study period. In 1999, there
was a switchover from ICD-9 to ICD-10. Two studiesconducted in Spain concluded that the introduction of
ICD-10 caused no important changes to the causes ana-
lysed here [57,58]. The classification of CTs into SES
was performed using accumulated data from the 2001
census and remained the same throughout the study
period, which was relatively short. Regarding SES classi-
fications used in this study, we should mention that the
relative risks estimated between the most favoured and
least favoured categories show, for each city, the relative
risk between the worst and the best population group in
all indicators used. Thus, the interpretation of these rela-
tive risks differs from that obtained using other classifi-
cations based on percentiles or the continuous value of
socioeconomic indicators composed from originals, and
reports the level of extreme inequalities between cat-
egories which could be identified as maximum and mini-
mum deprivation. This classification makes it possible to
identify the most deprived areas, which require greater
surveillance and attention, and the consistency of the re-
sults obtained using this classification is worth noting.
Another aspect to be taken into account is that the term
mortality, avoidable or not, takes only deaths, but not
other health outcomes, into consideration. This gives an
limited view of overall health outcomes, such as suicides,
by not providing information about suicide attempts in-
stead of deaths, or that it is not the best indicator of the
efficacy of preventive measures, such as the reduction in
accident injuries or improvements in quality of life as
outcomes other than death.
The mortality analysed in this study may be reduced by
means of well-designed health interventions and policies
aimed at preventing disease and disability. Several mea-
sures established by Spanish governments since the be-
ginning of this century, for example in road safety,
established as a priority in 2004, or campaigns aimed at
reducing tobacco use, which made it possible to introduce
the smoking ban, may be effective in reducing mortality,
but transferring the effects of these measures to the reduc-
tion of socioeconomic inequalities in mortality requires
investments in public health activities to promote health
Nolasco et al. International Journal for Equity in Health  (2015) 14:33 Page 13 of 15and prevent disease. These activities include efforts in
monitoring the state of health of the community, investi-
gating the areas at most risk, educating the population re-
garding health risks and prevention strategies, intensifying
health promotion initiatives, and reinforcing and adapting
laws and regulations. In this line, primary healthcare may
play an important role in contributing to reducing health
inequalities. Hernández et al. [59] proposes recommenda-
tions made by the Spanish Commission for the Reduction
of Health Inequalities, for putting actions of this type into
effect.
The period studied here falls within a period of eco-
nomic boom in the country, ending in 2007, when the
current world economic crisis, which having serious ef-
fects in Spain, commenced. Accordingly, this work aims
to serve as a point of reference for future studies which
evaluate trends in inequalities in preventable mortality in
later periods.
Conclusions
This study shows that preventable mortality analysed de-
creased between the 1996–2001 and 2002–2007 periods,
more markedly in men than in women, and that there
were socioeconomic inequalities in mortality in most cities
analysed, particularly among the youngest population, as-
sociating a higher risk of death with higher levels of
deprivation. Moreover, inequalities emained over the two
periods analysed. This type of study makes it possible to
identify those areas where excess preventable mortality is
associated with more deprived zones. It is in these de-
prived zones where actions to reduce and monitor health
inequalities should be put into place. Primary healthcare
may play an important role in this process.
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